| |||||||||||||||||||||
|
Recent Newsletters
FDA’s approval process puts heart patients at risk | Redo TAVR in Evolut valves | US Heart & Vascular's new partnership |
Heart Health Highlights: New diet lowers risk of type 2 diabetes | Key recalls | Clopidogrel vs. aspirin after PCI |
Medtronic layoffs | Cardiologist charged with sexual assault | An update from Damar Hamlin |
New details on the link between CVD & cancer | HeartFlow announces launch of AI offering |
New data on ACS & TAVR | Improving the accuracy of near-infrared fluorescence imaging | NSAID use & T2D |
Interventional Cardiology Highlights: Clopidogrel vs. aspirin after PCI | Maintaining quality in ASCs | Intravascular imaging |
Helping cardiologists communicate | FDA clears new Abbott device | Statins & chemotherapy side effects |